ホーム>>Signaling Pathways>> JAK/STAT Signaling>> STAT>>AS1517499

AS1517499

カタログ番号GC19039

AS1517499 は、強力で脳透過性の STAT6 リン酸化阻害剤であり、IC50 は 21 nM です。

Products are for research use only. Not for human use. We do not sell to patients.

AS1517499 化学構造

Cas No.: 919486-40-1

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$76.00
在庫あり
1mg
$30.00
在庫あり
2mg
$42.00
在庫あり
5mg
$73.00
在庫あり
10mg
$112.00
在庫あり
25mg
$173.00
在庫あり
50mg
$258.00
在庫あり
100mg
$379.00
在庫あり
500mg
$817.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of AS1517499

AS1517499 is a potent and brain-permeable STAT6 inhibitor with IC50 of 21 nM. AS1517499 often plays a role in the treatment of renal fibrosis and Keloids[1-2].

AS1517499 inhibited the proliferation of keloid fibroblasts (KFs) and normal skin tissue fibroblasts (NFs) with IC50 values of 1055-1958 nM and 3688-4130 nM, respectively, and AS1517499 significantly downregulated the expression of p-STAT6 in KF at 400 and 800 nM[2]. AS1517499 significantly downregulated the transcriptional levels of M2 macrophage-related genes (t IL−10 = 5.403, t TGF−β = 7.213, t CD206 = 48.940, t Arg1 = 11.253), and could also completely inhibit and block the STAT6/PPARγ pathway and the activation of macrophage M2 polarization[3].

AS1517499 (10 mg/kg ) can effectively reduce the levels of Th2-related cytokines in atopic dermatitis(AD) mice, alleviate airway eosinophil and lymphocyte infiltration, and regulate GATA3/Foxp3 levels and subepithelial collagen deposition[4]. AS1517499 (10 mg/kg) effectively inhibited the activation of STAT6 observed in mouse peritoneal macrophages and spleen after injection of zymosan. Furthermore, AS1517499 reduced the zymosan-mediated increase in IL-10, TGFβ, and HGF in peritoneal lavage fluid (PLF)[5].

References:
[1] Jiao B, An C, Tran M, et al. Pharmacological inhibition of STAT6 ameliorates myeloid fibroblast activation and alternative macrophage polarization in renal fibrosis[J]. Frontiers in immunology, 2021, 12: 735014.
[2] Chao H, Zheng L, Hsu P, He J, Wu R, Xu S, Zeng R, Zhou Y, Ma H, Liu H, Tang Q. IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation. JCI Insight. 2023 Mar 22;8(6):e157091.
[3] Yan S W, Zhang R, Guo X, et al. Trichinella spiralis dipeptidyl peptidase 1 suppressed macrophage cytotoxicity by promoting M2 polarization via the STAT6/PPARγ pathway[J]. Veterinary Research, 2023, 54(1): 77.
[4] Li X, Han Z, Wang F, et al. The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2, 4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway[J]. Allergy, Asthma & Clinical Immunology, 2022, 18(1): 12.
[5] Lee, Y.-J.; Kim, K.; Kim, M.; Ahn, Y.-H.; Kang, J.L. Inhibition of STAT6 Activation by AS1517499 Inhibits Expression and Activity of PPARγ in Macrophages to Resolve Acute Inflammation in Mice. Biomolecules 2022, 12, 447.

Protocol of AS1517499

Cell experiment [1]:

Cell lines

Keloid fibroblasts (KFs) and normal skin tissue fibroblasts (NFs)

Preparation Method

Primary fibroblasts were treated with AS1517499 at concentrations ranging from 3.387 nM to 200 μM for 3 days, and the sensitivity of primary fibroblasts to AS1517499 was analyzed using the CCK-8 assay.

Reaction Conditions

3.387 nM to 200 μM, 3 days

Applications

AS1517499 inhibits the proliferation of primary fibroblasts KFs and NFs with IC50 values of 1055-1958 nM and 3688-4130 nM, respectively.

Animal experiment [2]:

Animal models

Intracardiac Brain Metastasis Model

Preparation Method

One week after intracardiac injection of 4T1-GFP cells, mice were subcutaneously implanted with osmotic minipumps. After 48 hours of in vivo priming, mice were treated with AS1517499 (11.43 mg/mL;10.6 mg/kg/week) or vehicle (50% DMSO in water) for 7 days.

Dosage form

10.6 mg/kg/week, 7days, s.c.

Applications

AS1517499 treatment suppressed the anti-inflammatory phenotype of BDM/microglia, and reduced Arg1 expression in TMEM119+F4/80+ microglia.

References:
[1]. Chao H, Zheng L, Hsu P, He J, Wu R, Xu S, Zeng R, Zhou Y, Ma H, Liu H, Tang Q. IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation. JCI Insight. 2023 Mar 22;8(6):e157091.
[2]. Economopoulos V, Pannell M, Johanssen V A, et al. Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis[J]. Frontiers in Oncology, 2022, 12: 850656.

Chemical Properties of AS1517499

Cas No. 919486-40-1 SDF
Canonical SMILES O=C(C1=CN=C(NCCC2=CC=C(O)C(Cl)=C2)N=C1NCC3=CC=CC=C3)N
Formula C20H20ClN5O2 M.Wt 397.86
溶解度 DMSO : ≥ 35 mg/mL (87.97 mM) Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of AS1517499

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.5134 mL 12.5672 mL 25.1345 mL
5 mM 0.5027 mL 2.5134 mL 5.0269 mL
10 mM 0.2513 mL 1.2567 mL 2.5134 mL
  • モルアリティ計算機

  • 希釈計算機

  • Molecular Weight Calculator

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution) of AS1517499

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

レビュー

Review for AS1517499

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AS1517499

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.